Back to Resource Center

Multipurpose Prevention Technologies (MPTs): a promising response to current challenges around hormonal contraceptive methods & HIV

Multipurpose Prevention Technologies (MPTs): a promising response to current challenges around hormonal contraceptive methods & HIV

This panel session provided an overview of recent data on various hormonal contraceptive methods and HIV acquisition in HIV-negative women and gave an update of current evidence on drug interactions between various contraceptive hormones and specific antiretroviral (ARV) drugs. The session also highlighted the market access work being done by the IMPT and efforts to ensure that MPTs will be desirable, acceptable, and accessible to women and adolescent girls once commercially available. A live webinar with highlights from the presentations was held on 8 March 2016.

Moderator: Kirsten Vogelsong (Bill & Melinda Gates Foundation)
Presenters: Chelsea Polis (Guttmacher Institute), Anke Hemmerling (IMPT/UCSF), and Laura Dellplain (IMPT)

• View PPT Presentation from 27 Jan 2016
• View Webinar Recording from 08 Mar 2016

March 2016

Click for full info +

Multipurpose Prevention Technologies (MPTs): a promising response to current challenges around hormonal contraceptive methods & HIV

Multipurpose Prevention Technologies (MPTs): a promising response to current challenges around hormonal contraceptive methods & HIV
08 March 2016

This panel session provided an overview of recent data on various hormonal contraceptive methods and HIV acquisition in HIV-negative women and gave an update of current evidence on drug interactions between various contraceptive hormones and specific antiretroviral (ARV) drugs. The session also highlighted the market access work being done by the IMPT and efforts to ensure that MPTs will be desirable, acceptable, and accessible to women and adolescent girls once commercially available. A live webinar with highlights from the presentations was held on 8 March 2016.

Moderator: Kirsten Vogelsong (Bill & Melinda Gates Foundation)
Presenters: Chelsea Polis (Guttmacher Institute), Anke Hemmerling (IMPT/UCSF), and Laura Dellplain (IMPT)

• View PPT Presentation from 27 Jan 2016
• View Webinar Recording from 08 Mar 2016

Vogelsong, K., Polis, C., Hemmerling, A., & Dellplain, L.

In this Webinar:
Health Risk(s):

  • HIV
  • STI / STD
  • Unintended Pregnancy
    • Product Type(s):

  • MPTs
    • Topic(s):

  • Education
  • MPTs
    • Region(s):

  • Global


    • Full Info:


    Resource Type:

    Webinar

    Citation:

    Live webinar featuring highlights from the panel session at the 2016 International Conference on Family Planning (ICFP).

    Authors: Vogelsong, K., Polis, C., Hemmerling, A., & Dellplain, L.

    Health Risks(s):

    • HIV
    • STI / STD
    • Unintended Pregnancy

    Product type(s):

    • MPTs

    Topic(s):

    • Education
    • MPTs

      Region(s)

      • Global

      Additional Keywords:

      IMPT Education MPTs Unintended Pregnancy

      Back to Resource Center